Biopharmaceutical and antifungal properties of ellagic acid-cyclodextrin using an in vitro model of invasive candidiasis

Future Microbiology
Aline Vl GontijoMarcos J Salvador

Abstract

Aim: To investigate biopharmaceutical and antifungal properties of pure and complexed ellagic acid. Materials & methods: Caco-2 cells cultured in a Transwell® inserts were infected with Candida albicans to develop an in vitro model. Ellagic acid was complexed with cyclodextrins. Microbial compositions, ellagic acid concentration as function of time and characterization studies of complexes were evaluated. Results: Ellagic acid presented ability to reduce C. albicans invasion, although this was not statistically significant. Its poor water solubility and absorption probably limited this ability. Water solubility was increased after complexation with hydroxypropyl-β-CD; however, ellagic acid/hydroxypropyl-β-CD did not improve the antifungal activity. Conclusion: Although ellagic acid presented a promising antifungal activity, its biopharmaceutical properties limit such activity and should be improved.

References

May 1, 1975·The Journal of Surgical Research·J W DuttonE J Hinchey
May 1, 1994·Medicinal Research Reviews·J Szejtli
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Aug 16, 2005·International Journal of Pharmaceutics·Thorsteinn LoftssonMár Másson
Aug 23, 2005·Journal of Pharmaceutical and Biomedical Analysis·I BalaM N V Ravi Kumar
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema
Oct 30, 2009·Cellular Microbiology·Frederic DalleBernhard Hube
Nov 3, 2010·The Journal of Pharmacy and Pharmacology·Thorsteinn Loftsson, Marcus E Brewster
Dec 14, 2011·Nature Reviews. Microbiology·Neil A R GowMihai G Netea
Apr 13, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·José A Vazquez, Jack D Sobel
Jan 9, 2016·Annals of Intensive Care·Olivier LeroyUNKNOWN AmarCAND2 study group
Dec 7, 2016·Future Microbiology·Fernanda Lourenção BrighentiCristiane Yumi Koga-Ito
May 31, 2018·Planta medica·José-Luis RíosM Carmen Recio
Jul 19, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mehdi Sharifi-RadJavad Sharifi-Rad
Jul 24, 2018·Pharmaceutical Development and Technology·Ivan M SavicIvana M Savic-Gajic
Aug 15, 2018·International Journal of Molecular Sciences·Bahare SalehiJavad Sharifi-Rad
Sep 1, 2018·The Journal of Pharmacy and Pharmacology·Ivana Lj NikolicIvana M Savić-Gajic
Sep 27, 2018·Antimicrobial Agents and Chemotherapy·Aline da Graça SampaioCristiane Yumi Koga-Ito

❮ Previous
Next ❯

Citations

Jan 23, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Aline da Graça SampaioCristiane Yumi Koga-Ito

❮ Previous
Next ❯

Software Mentioned

GraphPad
LC real time LC solutions

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

© 2021 Meta ULC. All rights reserved